Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · IEX Real-Time Price · USD

8.43

-0.18 (-2.09%)

At close: Jul 2, 2024, 4:00 PM

8.48

+0.05 (0.59%)

After-hours: Jul 2, 2024, 6:44 PM EDT

Inovio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1997
Net Income	-135.12	-279.82	-303.66	-166.41	-119.36	Upgrade
Depreciation & Amortization	3.5	5.5	4.73	4.63	5.52	Upgrade
Share-Based Compensation	11.07	22.56	26.34	15.65	10.9	Upgrade
Other Operating Activities	-3.82	35.55	56.88	-31.84	5.09	Upgrade
Operating Cash Flow	-124.37	-216.22	-215.71	-177.98	-97.85	Upgrade
Capital Expenditures	5.9	-0.97	-1.23	-1.52	-0.99	Upgrade
Acquisitions	0	-2	0	35.95	0	Upgrade
Change in Investments	81.46	112.56	-174.11	-93.23	-8.06	Upgrade
Investing Cash Flow	87.36	109.59	-175.34	-58.8	-9.04	Upgrade
Share Issuance / Repurchase	5.46	83.24	216.11	466.76	9.2	Upgrade
Debt Issued / Paid	0	0	0	0.17	94.13	Upgrade
Other Financing Activities	-0.47	-1.4	-4.61	-1.65	2.07	Upgrade
Financing Cash Flow	5	81.84	211.5	465.28	105.4	Upgrade
Exchange Rate Effect	-0	-0.03	-0.03	0.03	0	Upgrade
Net Cash Flow	-32.02	-24.81	-179.58	228.53	-1.5	Upgrade
Free Cash Flow	-118.47	-217.18	-216.94	-179.5	-98.84	Upgrade
Free Cash Flow Margin	-14238.67%	-2116.34%	-12223.61%	-2422.00%	-2403.69%	Upgrade
Free Cash Flow Per Share	-5.34	-10.92	-12.47	-13.88	-12.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).